| Year |
Citation |
Score |
| 2016 |
Aprelikova O, Tomlinson CC, Hoenerhoff M, Hixon JA, Durum SK, Qiu TH, He S, Burkett S, Liu ZY, Swanson SM, Green JE. Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases. Plos One. 11: e0155262. PMID 27171183 DOI: 10.1371/Journal.Pone.0155262 |
0.567 |
|
| 2016 |
Aprelikova O, Chen K, El Touny LH, Brignatz-Guittard C, Han J, Qiu T, Yang HH, Lee MP, Zhu M, Green JE. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis. Clinical Epigenetics. 8: 38. PMID 27081402 DOI: 10.1186/S13148-016-0205-6 |
0.588 |
|
| 2013 |
Chu IM, Lai WC, Aprelikova O, El Touny LH, Kouros-Mehr H, Green JE. Expression of GATA3 in MDA-MB-231 triple-negative breast cancer cells induces a growth inhibitory response to TGFß. Plos One. 8: e61125. PMID 23577196 DOI: 10.1371/Journal.Pone.0061125 |
0.612 |
|
| 2013 |
Aprelikova O, Palla J, Hibler B, Yu X, Greer YE, Yi M, Stephens R, Maxwell GL, Jazaeri A, Risinger JI, Rubin JS, Niederhuber J. Silencing of miR-148a in cancer-associated fibroblasts results in WNT10B-mediated stimulation of tumor cell motility. Oncogene. 32: 3246-53. PMID 22890324 DOI: 10.1038/Onc.2012.351 |
0.403 |
|
| 2012 |
Bennett CN, Tomlinson CC, Michalowski AM, Chu IM, Luger D, Mittereder LR, Aprelikova O, Shou J, Piwinica-Worms H, Caplen NJ, Hollingshead MG, Green JE. Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer. Breast Cancer Research : Bcr. 14: R109. PMID 22812567 DOI: 10.1186/Bcr3230 |
0.542 |
|
| 2012 |
Aprelikova O, Green JE. MicroRNA regulation in cancer-associated fibroblasts. Cancer Immunology, Immunotherapy : Cii. 61: 231-7. PMID 22083346 DOI: 10.1007/S00262-011-1139-7 |
0.623 |
|
| 2012 |
Dahiya N, Bryant J, Aprelikova O, Neiderhuber J, Jazaeri AA. Abstract 801: Comparison of cisplatin induced changes in serous ovarian cancer and normal fallopian tube cells Cancer Research. 72: 801-801. DOI: 10.1158/1538-7445.Am2012-801 |
0.437 |
|
| 2011 |
Kim CH, Kim HK, Rettig RL, Kim J, Lee ET, Aprelikova O, Choi IJ, Munroe DJ, Green JE. miRNA signature associated with outcome of gastric cancer patients following chemotherapy. Bmc Medical Genomics. 4: 79. PMID 22112324 DOI: 10.1186/1755-8794-4-79 |
0.482 |
|
| 2011 |
Bratslavsky G, Sanford T, Srinivasan R, Aprelikova O, Liu J, Quezado M, Merino M, Linehan WM. Differential genetic expression in large versus small clear cell renal cell carcinoma: results from microarray analysis. Journal of Cancer. 2: 271-9. PMID 21611108 DOI: 10.7150/Jca.2.271 |
0.468 |
|
| 2010 |
Aprelikova O, Yu X, Palla J, Wei BR, John S, Yi M, Stephens R, Simpson RM, Risinger JI, Jazaeri A, Niederhuber J. The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts. Cell Cycle (Georgetown, Tex.). 9: 4387-98. PMID 20980827 DOI: 10.4161/Cc.9.21.13674 |
0.467 |
|
| 2010 |
Palla J, Aprelikova O, Yu X, John S, Yi M, Stevens R, Risinger J, Jazaeri A, Niederhuber J. Abstract 1430: Activation of WNT pathway in endometrial cancer stromal fibroblasts Cancer Research. 70: 1430-1430. DOI: 10.1158/1538-7445.Am10-1430 |
0.391 |
|
| 2010 |
Yu X, Aprelikova O, Palla J, John S, Yi M, Stephens R, Risinger JI, Jazaeri A, Niederhuber J. Abstract 1423: SatB2, targeted by miR31, is a modulator in cancer microenvironment Cancer Research. 70: 1423-1423. DOI: 10.1158/1538-7445.Am10-1423 |
0.535 |
|
| 2010 |
Bratslavsky G, Sanford T, Aprelikova O, Worrell R, Merino M, Srinivasan R, Linehan WM. 219 DIFFERENTIAL GENETIC EXPRESSION IN LARGE VERSUS SMALL CLEAR CELL RCC TUMORS IN THE SAME PATIENTS: RESULTS FROM MICROARRAY ANALYSIS Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.276 |
0.418 |
|
| 2009 |
Aprelikova O. The roads to tumor starvation. Cell Cycle (Georgetown, Tex.). 8: 2868. PMID 19736517 DOI: 10.4161/Cc.8.18.9742 |
0.434 |
|
| 2009 |
Aprelikova O, Pandolfi S, Tackett S, Ferreira M, Salnikow K, Ward Y, Risinger JI, Barrett JC, Niederhuber J. Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response Cancer Research. 69: 616-624. PMID 19147576 DOI: 10.1158/0008-5472.Can-08-0811 |
0.421 |
|
| 2009 |
Liu NW, Khurana KK, Sanford TH, Aprelikova O, Worrell R, Liu J, Gillespie J, Yang Y, Srinivasan R, Bechert CJ, Merino M, Pinto PA, Linehan WM, Bratslavsky G. IMPACT OF ISCHEMIA AND TISSUE PROCUREMENT CONDITIONS ON GENE EXPRESSION IN RENAL CELL CARCINOMA Journal of Urology. 181: 155-156. DOI: 10.1016/S0022-5347(09)60447-X |
0.313 |
|
| 2008 |
Salnikow K, Aprelikova O, Ivanov S, Tackett S, Kaczmarek M, Karaczyn A, Yee H, Kasprzak KS, Niederhuber J. Regulation of hypoxia-inducible genes by ETS1 transcription factor. Carcinogenesis. 29: 1493-9. PMID 18381358 DOI: 10.1093/Carcin/Bgn088 |
0.419 |
|
| 2007 |
Risinger JI, Chandramouli GV, Maxwell GL, Custer M, Pack S, Loukinov D, Aprelikova O, Litzi T, Schrump DS, Murphy SK, Berchuck A, Lobanenkov V, Barrett JC. Global expression analysis of cancer/testis genes in uterine cancers reveals a high incidence of BORIS expression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 1713-9. PMID 17363524 DOI: 10.1158/1078-0432.Ccr-05-2569 |
0.425 |
|
| 2006 |
Riss J, Khanna C, Koo S, Chandramouli GV, Yang HH, Hu Y, Kleiner DE, Rosenwald A, Schaefer CF, Ben-Sasson SA, Yang L, Powell J, Kane DW, Star RA, Aprelikova O, et al. Cancers as wounds that do not heal: differences and similarities between renal regeneration/repair and renal cell carcinoma. Cancer Research. 66: 7216-24. PMID 16849569 DOI: 10.1158/0008-5472.Can-06-0040 |
0.368 |
|
| 2006 |
Aprelikova O, Wood M, Tackett S, Chandramouli GV, Barrett JC. Role of ETS transcription factors in the hypoxia-inducible factor-2 target gene selection. Cancer Research. 66: 5641-7. PMID 16740701 DOI: 10.1158/0008-5472.Can-05-3345 |
0.358 |
|
| 2005 |
Jazaeri AA, Awtrey CS, Chandramouli GVR, Chuang YE, Khan J, Sotiriou C, Aprelikova O, Yee CJ, Zorn KK, Birrer MJ, Barrett JC, Boyd J. Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers Clinical Cancer Research. 11: 6300-6310. PMID 16144934 DOI: 10.1158/1078-0432.Ccr-04-2682 |
0.411 |
|
| 2005 |
Risinger JI, Maxwell GL, Chandramouli GV, Aprelikova O, Litzi T, Umar A, Berchuck A, Barrett JC. Gene expression profiling of microsatellite unstable and microsatellite stable endometrial cancers indicates distinct pathways of aberrant signaling. Cancer Research. 65: 5031-7. PMID 15958545 DOI: 10.1158/0008-5472.Can-04-0850 |
0.439 |
|
| 2004 |
Alleman WG, Tabios RL, Chandramouli GV, Aprelikova ON, Torres-Cabala C, Mendoza A, Rogers C, Rodgers C, Sopko NA, Linehan WM, Vasselli JR. The in vitro and in vivo effects of re-expressing methylated von Hippel-Lindau tumor suppressor gene in clear cell renal carcinoma with 5-aza-2'-deoxycytidine. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 7011-21. PMID 15501981 DOI: 10.1158/1078-0432.Ccr-04-0516 |
0.339 |
|
| 2004 |
Jazaeri AA, Chandramouli GV, Aprelikova O, Nuber UA, Sotiriou C, Liu ET, Ropers HH, Yee CJ, Boyd J, Barrett JC. BRCA1-mediated repression of select X chromosome genes. Journal of Translational Medicine. 2: 32. PMID 15383145 DOI: 10.1186/1479-5876-2-32 |
0.454 |
|
| 2004 |
Aprelikova O, Chandramouli GV, Wood M, Vasselli JR, Riss J, Maranchie JK, Linehan WM, Barrett JC. Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors. Journal of Cellular Biochemistry. 92: 491-501. PMID 15156561 DOI: 10.1002/Jcb.20067 |
0.309 |
|
| 2004 |
Alleman W, Chandramouli G, Aprelikova O, Tabios R, Linehan W, Vasselli J. 783: Gene Expression Analysis of the Effects of 5-Aza- 2'-Deoxycytidine On Hypermethylated VHL Clear-Cell Kidney Cancer Journal of Urology. 171: 207-207. DOI: 10.1016/S0022-5347(18)38032-7 |
0.459 |
|
| 2003 |
Risinger JI, Maxwell GL, Chandramouli GVR, Jazaeri A, Aprelikova O, Patterson T, Berchuck A, Barrett JC. Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer Cancer Research. 63: 6-11. PMID 12517768 |
0.394 |
|
| 2001 |
Aprelikova O, Pace AJ, Fang B, Koller BH, Liu ET. BRCA1 is a selective co-activator of 14-3-3 sigma gene transcription in mouse embryonic stem cells. The Journal of Biological Chemistry. 276: 25647-50. PMID 11384963 DOI: 10.1074/Jbc.C100265200 |
0.442 |
|
| 2001 |
Aprelikova O, Pace A, Koller B, Liu E. Differential gene expression in cells with targeted deletion of BRCA1 tumor suppressor Nature Genetics. 27: 39-39. DOI: 10.1038/86982 |
0.479 |
|
| 1996 |
Yarbrough WG, Aprelikova O, Pei H, Olshan AF, Liu ET. Familial tumor syndrome associated with a germline nonfunctional p16(INK4a) allele Journal of the National Cancer Institute. 88: 1489-1491. PMID 8841025 DOI: 10.1093/Jnci/88.20.1489 |
0.312 |
|
| 1993 |
Kaipainen A, Korhonen J, Pajusola K, Aprelikova O, Persico MG, Terman BI, Alitalo K. The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells. The Journal of Experimental Medicine. 178: 2077-88. PMID 8245783 DOI: 10.1084/Jem.178.6.2077 |
0.314 |
|
| Show low-probability matches. |